Author Archives: Katie Porter


Our Prediction for 2017: Out with Post Hoc and Go DeFT! 

It’s a new year and welcome to it! Pundits are making a lot of predictions about the decline of science and technology under the new administration in Washington DC, and I’m here with a contrarian view. We bet on biotechnology! We predict … Continue reading

Posted in Blog, Featured, News | Tagged , , , , , , | Leave a comment

Update: Screening for Immunogenicity: Immunotherapy Challenges and Predictive Approaches Applied to Therapeutic Proteins 

Update: This event has been cancelled by the organizers. Thank you for your interest. As an expert in immunogenicity screening, EpiVax’s CEO/CSO, Dr. Annie De Groot, will be conducting a training on state of the art methods of in silico and in … Continue reading

Posted in Events, Featured | Tagged , , , , , , , , , , , | Leave a comment

Creating Locally, Thinking Globally

EpiVax is now a member of Eurobiomed , a community bringing together scientific thought leaders with a common mission: Improve the health of all and as  quickly as possible. EpiVax, as a key player in the development of immunotherapies, will be … Continue reading

Posted in Blog, Events | Leave a comment

9th Annual Biotech Showcase

Join us at Biotech Showcase! Partnering opportunities are available! Click Here to schedule. Get leading-edge information on our latest immunoinformatics platform: An Innovative Computational Pipeline for Personalized Cancer Vaccine Design With superior identification of neo-antigens, EpiVax is using our validated vaccine design … Continue reading

Posted in Blog, Events | Tagged , , , | Leave a comment

Bio-Europe Spring

EpiVax will be joining more than 1,400 companies from over 45 countries at Bio-Europe Spring, the premier springtime partnering conference bringing together a “whoʼs who” from biotech, pharma and finance in Europe’s most innovative biopharma clusters. Partner with us to … Continue reading

Posted in Blog, Events, Featured, News | Tagged , , , , , , | Leave a comment